EU regulator begins to examine data on Russian vaccine

9
0
EU regulator begins to examine data on Russian vaccine

No date has yet been set for a meeting of experts who may advocate approval of the Sputnik V vaccine in the European Union

The European Medicines Agency said it has begun an ongoing analysis of data on Russia’s Sputnik V vaccine, months after it was first approved in Russia and approved for use in dozens of countries worldwide.

In a statement issued Thursday, the European regulator said the analysis is based on laboratory experiments and studies in adults that indicate the vaccine may protect against the coronavirus.

The agency has not set a date for a possible expert panel meeting to evaluate data on the Sputnik V vaccine to conclude whether it should be approved in the EU, but the ongoing analysis is intended to speed up the approval process, which usually takes several months.

ALSO READ:  A new vaccine against coronavirus will appear in Europe